Bernard Asselain

ScholarGPS® ID: 64536540089175

Affiliation

Institut Curie, France

Affiliation History

Field

Public Health

Discipline

Biostatistics

Top Specialties

Metrics Summary

Publication Count

545

Predicted Citations

20,845

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Phase Ib INEOV neoadjuvant trial of durvalumab +/- tremelimumab with platinum chemotherapy for patients (pts) with unresectable ovarian cancer (OC): Survival outcomes and immune correlates. (journal article) Leary, Alexandra \| Chardin, Laure \| Lortholary, Alain \| Asselain, Bernard \| Alexandre, Jerome \| Lebreton, Coriolan \| Savoye, Aude-Marie \| Oudard, Stephane \| Gavoille, Céline \| You, Benoit \| ... \| Pujade-Lauraine, Eric Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 5569-5569 (2024). 10.1200/JCO.2024.42.16_suppl.5569 Cite \| Source
Real-world effectiveness of post-trastuzumab emtansine treatment for human epidermal growth factor receptor 2-positive metastatic breast cancer: a multicenter, matched cohort analysis from the Epidemiology Strategy and Medical Economics database (2008-201 (journal article) Courtinard, C. \| Barbet, V. \| Schiappa, R. \| Pilleul, F. \| Michiels, S. \| Dabakuyo, S. \| Gourgou, S. \| Jaffre, A. \| Asselain, B. \| Bosquet, L. \| ... \| Delaloge, S. ESMO Real World Data and Digital Oncology, volume 4 (2024). 10.1016/j.esmorw.2024.100043 Cite \| Source
Updated outcomes of AdjuMel study: real-world data in patients with resected stage III-IV melanoma treated with adjuvant nivolumab in France (journal article) Dalle, S. \| Saiag, P. \| Lebbé, C. \| Grob, J.-J. \| Dréno, B. \| Dalac, S. \| Asselain, B. \| Skowron, F. \| Darras, S. \| Jovenin, N. \| ... \| Mortier, L. EJC Skin Cancer, volume 2 (2024). 10.1016/j.ejcskn.2024.100169 Cite \| Source
78P Final analysis of the French real-world study EVIDENS: Effectiveness, safety & quality of life at 36 months of nivolumab in advanced non-small cell lung cancer (NSCLC) (journal article) Barlesi, F. \| Dixmier, A. \| Debieuvre, D. \| Raspaud, C. \| Auliac, J.B. \| Benoit, N. \| Bombaron, P. \| Moro-Sibilot, D. \| Asselain, B. \| Audigier-Valette, C. \| ... \| Pérol, M. Immuno-Oncology and Technology, volume 20 (2023). 10.1016/j.iotech.2023.100550 Cite \| Source
Données de vie réelle chez des patients atteints de mélanome réséqué de stade III-IV et traités par nivolumab (NIVO) en situation adjuvante : résultats intermédiaires de l’étude ADJUMEL en France (journal article) Dalle, S. \| Saiag, P. \| Lebbé, C. \| Grob, J.J. \| Dreno, B. \| Dalac, S. \| Asselain, B. \| Skowron, F. \| Darras, S. \| Jovenin, N. \| ... \| Mortier, L. Annales de Dermatologie et de Vénéréologie - FMC, volume 3, issue 8, pages A361- (2023). 10.1016/j.fander.2023.09.610 Cite \| Source
Treatments During Pregnancy Targeting ERBB2 and Outcomes of Pregnant Individuals and Newborns (journal article) Gougis, Paul \| Grandal, Beatriz \| Jochum, Floriane \| Bihan, Kevin \| Coussy, Florence \| Barraud, Solenn \| Asselain, Bernard \| Dumas, Elise \| Sebbag, Clara \| Hotton, Judicael \| ... \| Hamy, Anne-Sophie JAMA Network Open, volume 6, issue 10, pages e2339934- (2023). 10.1001/jamanetworkopen.2023.39934 Cited by (2) \| Cite \| Source
Analyse finale de l’étude EVIDENS par région française : survie et tolérance en vie réelle à 3 ans des patients atteints d’un cancer bronchique non à petites cellules (CBNPC) traités par nivolumab (journal article) Sibilot, D. Moro \| Barlesi, F. \| Dixmier, A. \| Raspaud, C. \| Auliac, J.B. \| Bombaron, P. \| Debieuvre, D. \| Asselain, B. \| Gauthier, E. \| Audigier-Valette, C. \| ... \| Pérol, M. Revue des Maladies Respiratoires Actualités, volume 15, issue 1, pages 130- (2023). 10.1016/j.rmra.2022.11.185 Cite \| Source
Real-world first-line treatment of patients with BRAFV600E-mutant metastatic colorectal cancer: the CAPSTAN CRC study (journal article) Martinelli, E. \| Cremolini, C. \| Mazard, T. \| Vidal, J. \| Virchow, I. \| Tougeron, D. \| Cuyle, P.-J. \| Chibaudel, B. \| Kim, S. \| Ghanem, I. \| ... \| Arnold, D. ESMO Open, volume 7, issue 6, pages 100603- (2022). 10.1016/j.esmoop.2022.100603 Cited by (7) \| Cite \| Source
Phase Ib INEOV neoadjuvant trial of durvalumab +/- tremelimumab with platinum chemotherapy for patients (pts) with unresectable ovarian cancer (OC): Final complete resection and pathological response rates. (journal article) Leary, Alexandra \| De La Motte Rouge, Thibault \| Lortholary, Alain \| Asselain, Bernard \| Alexandre, Jerome \| Floquet, Anne \| Savoye, Aude Marie \| Delanoy, Nicolas \| Gavoille, Céline \| You, Benoit \| ... \| Pujade-Lauraine, Eric Journal of Clinical Oncology, volume 40, issue 16_suppl, pages 5557-5557 (2022). 10.1200/JCO.2022.40.16_suppl.5557 Cited by (1) \| Cite \| Source
EVIDENS : première analyse par région française des données de vie réelle de la prise en charge des patients atteints d’un cancer bronchique non à petites cellules (CBNPC) traités par nivolumab (journal article) Debieuvre, D. \| Barlesi, F. \| Dixmier, A. \| Raspaud, C. \| Auliac, J.B. \| Nicolas, B. \| Bombaron, P. \| Moro-Sibilot, D. \| Asselain, B. \| Cotte, F.E. \| ... \| Pérol, M. Revue des Maladies Respiratoires Actualités, volume 14, issue 1, pages 198-199 (2022). 10.1016/j.rmra.2021.11.349 Cite \| Source
Survival Outcomes after Hyperthermic Intraperitoneal Chemotherapy for a First Ovarian Cancer Relapse: A Systematic Evidence-Based Review (journal article) Classe, Jean-Marc \| Asselain, Bernard \| Campion, Loic \| Berton, Dominique \| Frenel, Jean-Sébastien \| Lécuru, Fabrice \| Ferron, Gwenael \| Gladieff, Laurence \| Bourgin, Charlotte \| Loaec, Cecile Cancers, volume 14, issue 1, pages 172- (2021). 10.3390/cancers14010172 Cited by (2) \| Cite \| Source
LBA33 Maintenance olaparib rechallenge in patients (pts) with ovarian carcinoma (OC) previously treated with a PARP inhibitor (PARPi): Phase IIIb OReO/ENGOT Ov-38 trial (journal article) Pujade-Lauraine, E. \| Selle, F. \| Scambia, G. \| Asselain, B. \| Marmé, F. \| Lindemann, K. \| Colombo, N. \| Madry, R. \| Glasspool, R.M. \| Dubot, C. \| ... \| Redondo, A. Annals of Oncology, volume 32 (2021). 10.1016/j.annonc.2021.08.2110 Cited by (50) \| Cite \| Source
1348P Long-term survival and health-related quality of life with nivolumab for previously-treated advanced non-small cell lung cancer (NSCLC): A wide prospective French real-world study (EVIDENS) (journal article) Barlesi, F. \| Dixmier, A. \| Debieuvre, D. \| Raspaud, C. \| Auliac, J.B. \| Nicolas, B. \| Bombaron, P. \| Moro-Sibilot, D. \| Audigier-Valette, C. \| Asselain, B. \| ... \| Pérol, M. Annals of Oncology, volume 32 (2021). 10.1016/j.annonc.2021.08.1949 Cite \| Source
821TiP GREAT: A multicentric cohort of advanced ovarian cancer (AOC) treated in real life with prospective collection of clinical data, tumor sample, and biomarkers (tBRCA, HRD) including genomic putative theranostic markers: A GINECO study (journal article) De La Motte Rouge, T. \| Berton, D. \| Kalbacher, E. \| Asselain, B. \| Collard, O. \| Rodrigues, M. \| Lefevre, L. Bengrine \| Rouleau, E. \| Nogues, C. \| Just, P.A. \| ... \| Pujade-Lauraine, E. Annals of Oncology, volume 32 (2021). 10.1016/j.annonc.2021.08.1263 Cite \| Source
727P Phase Ib INEOV neoadjuvant trial of the anti-PDL1, durvalumab (D) +/- anti-CTLA4 tremelimumab (T) with platinum chemotherapy for patients (pts) with unresectable ovarian cancer (OC): A GINECO study (journal article) Leary, A. \| De La Motte Rouge, T. \| Lortholary, A. \| Asselain, B. \| Alexandre, J. \| Floquet, A. \| Savoye, A.M. \| Chardin, L. \| Delanoy, N. \| Gavoille, C. \| ... \| Pujade-Lauraine, E. Annals of Oncology, volume 32 (2021). 10.1016/j.annonc.2021.08.1170 Cited by (4) \| Cite \| Source
438P First line treatment patterns in BRAFV600E-mutant metastatic colorectal cancer patients (mCRC): The CAPSTAN European retrospective study (journal article) Asselain, B. \| Martinelli, E. \| Cremolini, C. \| Mazard, T. \| Vidal, J. \| Virchow, I. \| Tougeron, D. \| Castagné, C. \| Zkik, A. \| Khan, S. \| Arnold, D. Annals of Oncology, volume 32 (2021). 10.1016/j.annonc.2021.08.959 Cited by (1) \| Cite \| Source
P-51 Baseline characteristics of patients enrolled in the CAPSTAN study: A European retrospective study in BRAFV600E-mutant metastatic colorectal cancer patients (journal article) Martinelli, E. \| Asselain, B. \| Cremolini, C. \| Mazard, T. \| Vidal, J. \| Virchow, I. \| Tougeron, D. \| Berradi, H. \| Castagné, C. \| Arnold, D. Annals of Oncology, volume 32 (2021). 10.1016/j.annonc.2021.05.106 Cite \| Source
Two-year survival with nivolumab in previously treated advanced non–small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and Canada (journal article) Debieuvre, Didier \| Juergens, Rosalyn A. \| Asselain, Bernard \| Audigier-Valette, Clarisse \| Auliac, Jean-Bernard \| Barlesi, Fabrice \| Benoit, Nicolas \| Bombaron, Pierre \| Butts, Charles A. \| Dixmier, Adrien \| ... \| Sebastian, Martin Lung Cancer, volume 157 (2021). 10.1016/j.lungcan.2021.04.022 Cited by (16) \| Cite \| Source
Absenteeism and indirect costs during the year following the diagnosis of an operable breast cancer: A prospective multicentric cohort study (journal article) Ferrier, Clement \| Thebaut, Clémence \| Levy, Pierre \| Baffert, Sandrine \| Asselain, Bernard \| Rouzier, Roman \| Hequet, Delphine Journal of Gynecology Obstetrics and Human Reproduction, volume 50, issue 6, pages 101871- (2021). 10.1016/j.jogoh.2020.101871 Cited by (7) \| Cite \| Source
Surgery for recurrent ovarian cancer: expert point of view (journal article) Schütz, Anna \| Taumberger, Nadja \| Pautier, Patricia \| Florence, Joly \| Ferron, Gwenael \| Classe, Jean-Marc \| Pujade-Lauraine, Eric \| Asselain, Bernard \| Lecuru, Fabrice Gynecology and Pelvic Medicine, volume 4 (2021). 10.21037/gpm-2020-13 Cite \| Source